Cardiovascular Diseases
Learn about the latest trends, discover events and innovations in the changing world of cardiovascular disease.
Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice
Hypercholesterolemia Treatment Patterns and Lipid Target in ACS Patients: HYDRA-ACS Registry
Prospective evaluation of lipid management following acute coronary syndrome in Saudi Arabia
Management of Patients With Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: 1-year Outcomes of The PERI-DYS Study
.webp/jcr:content/low-risk-vte-thumb%20(3).webp)
.webp/jcr:content/jcr_content%20(9).webp)
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
.webp/jcr:content/jcr_content%20(7).webp)
.webp/jcr:content/jcr_content%20(5).webp)
.webp/jcr:content/Use-of-Lipid-Lowering-Therapies-Over-2-Years-thumb%20(1).webp)
Use of Lipid-Lowering Therapies Over 2 Years
Prescription patterns of lipidlowering therapies over time in patients with atherosclerotic cardiovascular disease
Findings from Gould study
.webp3/jcr:content/jcr_content%20(1).webp)
The European experience: Swedeheart and AIFA registries
Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.
.webp/jcr:content/jcr_content%20(16).webp)
.webp/jcr:content/jcr_content%20(21).webp)
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry
Events
Stay up to date and register for the latest events and view webinar recordings.
.jpg/jcr:content/image%20(41).jpg)
.jpg/jcr:content/image%20(40).jpg)
